Esculetin is a coumarin derivative with high antioxidant activity. In a rat experimental model of inflammatory bowel disease induced by trinitrobenzenesulfonic acid, esculetin at the dose of 5mg/Kg displayed intestinal anti-inflammatory activity; however, its mechanism of action needs to be elucidated. Our objective was to evaluate the effects of esculetin on the intestinal inflammatory process and to clarify the mechanism of action of this compound. We also compared its effects with prednisolone and sulphasalazine. Our results demonstrate that treatment with esculetin prevented an increase in malondialdehyde content, counteracted the depletion of glutathione content, reduced epithelial cell apoptosis, reduced the secretion of pro-inflammatory cytokines, such as IL-lP, IL-2 and IFN-y, in vitro, and reduced the colonic levels of TNF-a and IL-IP in vivo. Additionally, esculetin treatment inhibited MPO and AP activities. These results demonstrated that esculetin produced a more effective intestinal anti-inflammatory effect than sulphasalazine because it was used at a lO-fold lower dose, and it produced effects similar to those created by prednisolone. We suggest that esculetin exerts its activity by inhibiting pro-inflammatory cytokine secretion and increasing the defences against reactive oxygen species. This leads to less migration and/or activation of inflammatory cells, resulting in the improvement of lesions and functions in the intestinal epithelium. This study confirms the intestinal anti-inflammatory activity of esculetin and demonstrates that this compound has both antioxidative and immunomodulatory properties. Therefore, esculetin may be an interesting new anti-inflammatory drug for the treatment of inflammatory bowel disease.
treatment include aminosalicylates, corticosteroids and immunosuppressants, such as azathioprine, methotrexate, cyclosporine, and more recently, a monoclonal antibody against tumour necrosis factor a (TNF-a). However, most ofthese drugs show some limitations when administered to IBD patients. For example, not all patients have an adequate response, and side effects frequently occur when these drugs are chronically administered. Moreover, these drugs do not represent the cure of these intestinal conditions.
It has been reported that excess reactive oxygen species and nitrogen metabolite production promotes disturbances of redox status and significantly contributes to the pathogenesis of IBD, thereby having a considerable impact on the course of the disease (2) . Based on this, the inhibition and! or neutralisation of these reactive metabolites or the activation of endogenous enzymatic and nonenzymatic antioxidant systems may be beneficial in IBD treatment (2) . In fact, it has been proposed that free radical scavenger activity may be responsible for the beneficial effects of sulphasalazine and other aminosalicylates used for the treatment of IBD.
Esculetin (6,7-dihydroxycoumarin) is a coumarin derivative with high antioxidant activity compared to other coumarins. Paya et al. ( 3) compared some coumarin derivatives in different protocols of antioxidant activities, and esculetin display a high antioxidant activity compared to other coumarins suggesting that compounds which present orthodihydroxy arrangement have a better antioxidant activity. In addition, it has been shown to inhibit the lipoxygenase and cyclooxygenase pathways of arachidonic acid metabolism (3) (4) (5) , reduce the expression of matrix metalloproteinases (6, 7) and downregulate the production of the cytokines IL-6 and IL-8 (8) . As evidenced by both in vitro and in vivo studies, these properties can account for the different biological effects of this compound, including its ability to decrease liver neutrophil infiltration (9) , attenuate sub-epithelial fibrosis and TGF-pi levels in the lung (10) and protect DNA against oxidative stress (4) . All these effects clearly contribute to the different pharmacological activities of esculetin, including analgesic effects (11) , anti-carcinogenic properties (12, 13) and immunomodulatory functions (14) . With regard to the latter activity, a previous study demonstrated the intestinal anti-inflammatory activity of this coumarin in an experimental model of colitis induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats (15) . Based on this finding, our objective was to evaluate the effects of esculetin on the intestinal inflammatory process to further clarify the mechanism of action of this compound. We also compared its effects to prednisolone and sulphasalazine, the primary drugs used for IBD treatment. This was performed to establish whether esculetin might be an alternative treatment for IBD with a better pharmacological profile and with minor side effects.
MATERIALS AND METHODS

Materials
All chemicals, including esculetin, prednisolone and sulphasalazine, were provided by Sigma (Sao Paulo, Brazil), unless otherwise stated. The test substances were dissolved in methylcellulose (1% w/v) and were prepared fresh daily for administration to the animals.
Animals
Male Wistar rats, weighing 180-200 g, were obtained from the Central Animal House of the Sao Paulo State University (UNESP) (Botucatu, Sao Paulo, Brazil) and were housed in standard environmental conditions (21°C, 60-70% humidity) with a 12 h light/dark cycle and air filtration. The animals had free access to water and food (Biobase, Sao Paulo, Brazil). The experimental protocols adhered to the "Guidelines of Animal Experimentation" approved by the Commission of Ethics in Animal Experimentation (Protocol number 042/04-CEEA), Institute of Biosciences, Sao Paulo State University (UNESP).
Induction of colitis and assessment of the inflammatory process
Colitis was induced using the method originally described by Morris (16) . Briefly, animals were fasted overnight and then anaesthetised with halothane. While under anaesthesia, the rats were administered 10 mg of TNBS dissolved in 0.25 ml of 50% ethanol (v/v) with a Teflon cannula inserted 8 em into the anus. During and after TNBS administration, the rats remained in a headdown position until they recovered from the anaesthesia. Rats from the non-colitic group received 0.25 ml of saline instead ofTNBS. Two different protocols were followed.
Acute colitis: Rats (n=8) received 5 mg/kg esculetin, 2 mg/kg prednisolone or 50 mg/kg sulphasalazine orally at 96, 72, 48, 24, and 2 hours prior to induction of colitis.
A dose of 5 mg/Kg for esculetin was chosen based on the dose-response study previously performed in our laboratory (15) . The drugs were administered by means of an oesophageal catheter (volume: 5 ml/kg). The following two additional groups were included for reference: a noncolitic group that received saline intracolonically and the oral vehicle and a TNBS-control group that received only TNBS and the vehicle (5 ml/kg methylcellulose) orally. The animal body weights, the occurrence of diarrhoea, as detected by perianal fur soiling, and the total food intake for each group were recorded daily. Animals from all groups (n=8) were euthanized 48 h after colitis induction with an overdose of halothane.
Colitis relapse: In this protocol, colitis was initially induced with 10 mg ofTNBS in 50% ethanol, as described previously.After 14 days, the animals were given a second dose of 10 mg of TNBS to mimic the common relapses experienced by humans with IBD. The animals were divided into three groups, which were treated daily with the same drugs and doses used in the acute colitis protocol. The non-colitic and TNBS-control groups were similar to the acute colitis group. Treatments started 2 h after the first administration of TNBS and continued until the day before the animals were euthanized. Animals from each group (n=8) were euthanized after 1,2 or 3 weeks of colitis induction, whereas the animals that received only the first dose of TNBS (TNBS-control without relapse) and the vehicle were euthanized after 3 weeks. The animals were euthanized with an overdose of halothane.
The colonic segments were obtained after laparotomy, and the occurrence of adhesions between the colon and adjacent organs was noted. The colonic segments were placed on an ice-cold plate, cleaned of fat and mesentery, and blotted on filter paper. The colon was weighed and its length was measured under a constant load (2 g). The colon was opened longitudinally and scored for macroscopically visible damage on a 0-10 scale by two observers blinded to the treatments, according to the criteria described by Bell (17) . The colon was subsequently divided longitudinally into different pieces to be used for the following biochemical assays: myeloperoxidase (MPO) activity, alkaline phosphatase (AP) activity, total glutathione (GSH) content, malondialdehyde content (MDA), matrix metalloproteinase (MMP-9 and MMP-2) activities, and tumour necrosis factor alpha (TNF-a) and interleukin 1~(IL-l~) levels. All samples were frozen at -80°C until processing.
Biochemical assays in colonic specimens Myeloperoxidase (MPO) activity
The MPO activity was measured according to the technique described by Krawisz (18) . Briefly, the samples were resuspended in 1 ml of 50 mM phosphate buffer containing 0.5% hexadecyltrimethylammonium bromide (pH 6.0) and minced with scissors for 15 s on an ice-cold plate. The resultant suspension was subsequently diluted to a final ratio of 1:20 w/v, homogenised for 1 minute with an automatic Heidolph homogeniser, sonicated for 10 s and subjected to three freeze-thaw cycles. The homogenates were then centrifuged at 7000 x g at 4°C for 10 minutes, and the supernatants were assayed for MPO activity. The results are expressed as MPO units per g of wet tissue.
Alkaline phosphatase (AP) activity
AP activity was measured spectrophotometrically using disodium nitrophenyl phosphate (5.5 mM) as the substrate in 50 mM glycine buffer containing 0.5 mM MgCI 2 , pH 10.5 (19) . The results are expressed as mU per mg of protein.
Glutathione (GSH) content
The total GSH content was quantified with the recycling assay described by Anderson (20) . Briefly, the samples were thawed, minced, diluted to a concentration of 1:20 (w/v) in ice-cold 5% trichloroacetic acid (w/v) and homogenised. The homogenates were centrifuged at 7000 x g for 15 minutes at 4°C, and the supernatants were used to quantify the glutathione content. The results are expressed as nmol per g of wet tissue.
TNF-a and 1L-1/3 levels
Colonic samples for the determination of TNF-a and IL-l~levels were weighed, homogenised, minced on an ice-cold plate and resuspended in a centrifugation tube containing 10 mM/L sodium phosphate buffer pH 7.4 (1:5 w/v). The tubes were placed in a shaker submerged in a 37°C water bath for 20 minutes and then centrifuged at 9000 x g for 30 s at 4°C. The supernatants were frozen at -80°C until assayed. The TNF-a and IL-l~levels were quantified by a DuoSet ELISA Kit to measure the concentration of the natural and recombinant rat enzyme according to the manufacturer's instructions (R&D Systems, Inc., Minneapolis, Minnesota, USA). The results were expressed as pg per mg of protein. The protein dosage was performed by Bradford protein assay.
Production ofmalondialdehyde (MDA)
Tissue concentrations of MDA were determined as an index of lipid peroxidation by the methodology described by Zingarelli (21) . The tissue samples were homogenised in 1.15% KCl solution. An aliquot (400 ul) of the homogenate was added to a reaction mixture containing 200 !J.l of 8.1% sodium dodecyl sulphate (SDS), 1500 ul of 20% acetic acid pH 3.5, 1500 ul of 0.8% thiobarbituric acid, and 400 ul of distilled water.
The samples were then boiled for one hour at 95°C and centrifuged at 3000 x g for 10 minutes. The absorbance of the supernatant was spectrophotometrically measured at 532 nm and compared to a standard curve obtained using 1,1,3,3-tetramethoxypropane. The data were expressed as nmol per g of wet tissue.
Gelatine zymography for MMP-2 and MMP-9
Zymographic analyses were used to evaluate the gelatinolytic activity of MMP-2 and MMP-9 in rat colons (n=8). Frozen samples of rat colons from all experimental animals were mechanically homogenised in a solution of50 roM Tris-HCI pH 7.5 containing 0.25% Triton X-I00 and 10 roM CaCl z . For every 30 mg of colonic tissue, 0.1 mlof the solution was used. Aliquots of 20 ug of protein were subjected to electrophoresis under non-reducing conditions in an 8% polyacrylamide gel co-polymerised with 0.1% gelatine. After electrophoresis, the gels were washed twice for IS min in a solution of 2.5% Triton X-I 00 to remove the sodium dodecyl sulphate (Bio-Rad, CA, USA). This was followed by two washes in a buffer solution of 50 mM Tris-HCI pH 8.0 for 5 min. The gels were then incubated overnight in Tris-HCI buffer containing 5 roM CaCl z at 37°C. Finally, the gels were stained with Coomassie Brilliant Blue R-250. The bands were analysed on an Image Master VOS 3.0 (Pharmacia Biotech). The values are expressed as the integrated optical densities.
Histological findings
Representative whole gut specimens were taken from a region of the inflamed colon corresponding to the segment adjacent to the gross macroscopic damage. These sections were fixed in 4% buffered formaldehyde. Cross-sections were selected and embedded in paraffin. Equivalent colonic segments were also obtained from the non-colitic group. Full-thickness 6-Jlm sections were obtained at different levels and stained with haematoxylin and eosin. After staining, the images were subjected to analysis and photomicrography. A Leica microscope with the Leica Qwin Plus version 3.3 e 3.40 software was used for the evaluation of histological damage. The scoring methodology described by Stucchi (22) was utilized for this evaluation.
The Feulgen reaction technique (23) was also performed on a separate histological section to analyse the degree of nuclear chromatin compaction in the crypt epithelial cells. This indicated the degree of apoptosis in these cells. The results were expressed as the number of apoptotic cells divided by the number of total crypts.
In vitro effects ofesculetin on cytokine production Effects on IL-JfJ production by RA W264. 7 cells
The murine macrophage cell line, RAW264.7, was obtained from the Cell Culture Unit of the University of Granada (Granada, Spain) and cultured in Oulbecco's Modified Eagle's Medium (OMEM) supplemented with 10%FBS and 2 mM L-glutamine. The cells were maintained in a humidified 5% COzatmosphere at 37°C. The cells were seeded onto 24-well plates at a density of 5xlO s cells per well and grown until confluent. They were then incubated for 30 min with different concentrations of esculetin (1-100 JlM). Subsequently, the cells were stimulated with LPS (50 pg/ml) for 20 h, and the supernatants were collected, centrifuged at 10000 x g for 5 min, and frozen until ELISA analysis of the IL-l~concentration.
Effects on IL-8 production by Caco-2 cells
The human colon adenocarcinoma cell line, Caco-2, obtained from the Cell Culture Unit of the University of Granada (Granada, Spain), was used to test the ability of esculetin to inhibit the production and/or release of IL-8. Cells were grown in OMEM supplemented with 10% FBS and 2 mM L-glutamine in a humidified 5% CO 2 atmosphere at 37°C. Caco-2 cells were seeded onto 24well plates at a density of 5xl 05 cells per well and grown until confluent. They were then incubated for 30 min with different concentrations of esculetin (I -100 JlM). Following this, the cells were stimulated with IL-l~(I ng/ml) for 20 h, and the supernatants were collected, centrifuged at 10000 x g for 5 min, and frozen until ELISA analysis of the IL-8 concentration.
Effects on IFN-y andIL-2 production by mouse splenocytes
Splenocytes were obtained from male, 8-weekold BALB/c mice provided by the Laboratory Animal Service of the University of Granada (Granada, Spain). The mice were euthanized with an overdose of halothane, and the spleens were removed and homogenised in OMEM containing 1% penicillin/streptomycin. After centrifugation at 1500 x g for 5 min, the erythrocytes were lysed in a buffer composed of 1.7 mol/L NH 4CI, 0.12 mol/L KHC0 3 and 9 mM/L ethylenediaminetetraacetic acid for 30 min at 4°C. Resting cells were counted with a haemocytometer and cultured for proliferation and stimulation assays. The cells were grown in OMEM supplemented with 10% FBS and were incubated at 37°C in a humidified 5% COz atmosphere. These cells were incubated for 1 h with different concentrations of esculetin (I, 10, 50 or 100 JlM). Subsequently, the cells were stimulated with concanavalin A (5 Jlg/ ml) for 48 h, and the supernatants were collected, centrifuged at 10000 x g for 5 min and frozen at -80°C until ELISA analysis of the IFN-y and IL-2 concentrations.
Cell viability assays
The viability of the spleen-derived lymphocytes was quantified using WST-l reagent (Roche, Germany), following the protocol previously described (24) . Cell viability was also determined by conventional trypan blue staining and cell counting using a haemocytometer. Caco-2 and RAW264.7 cell viability was determined by crystal violet staining. Briefly, the cells were stained with 0.2% crystal violet in ethanol for 30 min at room temperature. The plates were then washed 4 times with PBS. The cells were solubilised with 1% sodium dodecyl sulphate solution for 30 min. The cells were then centrifuged at 3000 x g for 5 min, and the dye uptake was measured at 540 nm using a microplate reader.
Statistics
All results are expressed as the mean ± S.E.M., and the differences between the mean values were tested for statistical significance using one-way analysis of variance (ANOVA). Nonparametric data (score) are expressed as the median (range) and were analysed with the Kruskal-Wallis test. The differences between the proportions were analysed with the "l test. Statistical significance was set atp < 0.05.
RESULTS
Acute colitis
Intracolonic administration of TNBS resulted in colonic inflammation, and in comparison to the non-colitic rats, the TNBS-control group showed a reduction in food intake (data not shown) and signs of diarrhoea (Table I) . This induced a significant reduction in body weight (data not shown). After 48 hours, the colonic macroscopic damage was characterised by severe necrosis of the mucosa, typically extending 6-7 em along the colon, and bowel wall thickening, as evidenced by an increase in the colonic weight/length ratio (Table I ). In addition, most of the rats from this group showed adhesions between the colonic segment and adjacent organs (Table I) . Biochemically, the colonic damage was associated with significantly higher MPO, AP (Table II) and metalloproteinase-9 activities ( Fig. I) and TNF-a, IL-1P ( Fig. 1 ) and MDA content ( Table   Table I . Effects ofesculetin (5 mg/Kg), prednisolone (2 mg/Kg) and sulphasalazine (50 mg/Kg) treatment on macroscopic damage score, colonic weight, incidence ofdiarrhoea, adherence and apoptosis in acute TNBS colitis.
Group
Macroscopic II). Furthermore, significant colonic GSH depletion occurred in the inflamed colon from untreated colitic rats (Table II) . Esculetin showed a protective effect in colitic rats, as evidenced by a decrease in diarrhoea, adherence, and macroscopic score compared to the non-treated colitic group (Table I) . Biochemically, this protective effect was associated with counteract in GSH content (Table II) . The administration of either prednisolone or sulphasalazine also promoted a decrease in the macroscopic score, which was accompanied biochemically by inhibition in the AP and MPO activities and counteract GSH content (Table II) . When the pro-inflammatory cytokine levels were evaluated, only esculetin and prednisolone significantly reduced the colonic TNF-a level (Fig. I) .
The histological assessment of the colonic samples from the TNBS-control group revealed severe transmural disruption of the nonnal architecture of the colon, with extensi ve ulceration and inflammation involving all the intestinal layers of the colon. These samples were also characterised by severe oedema, interstitial micro -haemorrhages and diffuse leukocyte infiltration. This infiltrate is composed primarily of neutrophils, and to a lesser extent , lymphocytes and histiocytes. The samples were assigned a median score (range) of 16.5 (14-21) (Fig. 2 ). All treated group s showed a significant recovery of the intestin al cytoarchitecture, which was associated with a reduction in the extension of the ulcerated area and in the degree of tissue oedema and vascularisation. This resulted in significantl y lower values for the microscopic score compared to the TNBS-control group (Fig. 2 ). In addition , the number of apoptotic epithelial cells was increased 2-fold in the TNBS-control group compared to the non-colitic group. Treatment with esculetin, prednisolone or sulphasalazine significantly reduced the degree of apoptosis in the epithelial cells (Table  I) .
Colitis relapse
The colonic damage was maximal during the first week and decreased gradually during the following two weeks. However, the colonic segments remained macroscopically ulcerated and inflamed, with an increase in the colonic weight/length ratio throughout the experiment (Table III) .
The progress of the inflammatory process was also confirmed biochemically because MPO, AP and MMP-9 activities, TNF-a and IL-I~levels and MDA content were maximally increased in the seven days following the first TNBS administration (Table IV and V) . There was a significant decrease in the colonic glutathione content during all weeks (Table IV) . Microscopic evaluation of the colonic specimens revealed a similar damage profile over time.
One week after TNBS administration, esculetin treatment promoted a reduction in the macroscopic score (Table III) , inhibition of MPO, AP and MMP-9 activities (Tables IV and V) , reduction in MDA content (Table IV) , reduction in TNF-a and IL-Il evels (Table V) , and it counteracted the decrease in colonic GSH content (Table IV) . The impact of prednisolone treatment on the different biochemical markers studied was similar to that of esculetin treatment, whereas sulphasalazine prevented GSH depletion, inhibited MPO, AP and MMP-9 activities and reduced colonic IL-l~levels (Tables IV and V) . After two weeks, no significant differences were observed among the colitic groups when the different biochemical markers were evaluated. The one exception was colonic AP activity, which was significantly reduced by all treatments compared to the TNBS-control group (Table IV) . Additionally, all treated groups showed a reduction in the microscopic damage score (Table III) .
When colitis relapse was induced by a second dose of TNBS, a reactivation of the colonic inflammatory process was obtained. There was a significant increase in the macroscopic damage score compared to the normal evolution of colonic damage in those animals that did not receive the second dose of TNBS (TNBS-control without relapse) (Table  III ). In addition, the reactivation of the intestinal inflammatory process was associated with colonic oxidative damage that caused the depletion of glutathione content, together with an increase in MPO and AP activities (Table IV) and TNF-a and IL-l~levels (Table V) . The treatment with esculetin was similar to the treatments with prednisolone and sulphasalazine, in that it significantly reduced the macroscopic score, counteracted GSH content, and inhibited both MPO and AP activities (Table IV) . Of note, only esculetin treatment significantly reduced the colonic IL-I~levels, whereas prednisolone and sulphasalazine increased the levels of this proinflammatory cytokine (Table V) .
Finally, all treatments reduced the number of apoptotic epithelial cells during all weeks of treatment.
Inhibition ofcytokine production in cell cultures
Esculetin reduced the production of IL-Ib y LPS-stimulated RAW264.7 cells in a dosedependent manner, achieving a maximal reduction of 77.7% at a concentration of 100 flM (Fig. 3) . When IL-2 or IFN-y production was evaluated in mouse splenocytes, the highest concentration of esculetin assayed (100 flM) significantly reduced these cytokines levels. Esculetin reduced these levels by approximately 60% for IL-2 secretion and 65% for IFN-y production. No significant modification was observed by different concentrations of esculetin in IL-8 secretion induced in Caco-2 epithelial cells.
Only the highest concentration of esculetin affected the cell viability of the macrophage cell line RAW264.7 (promoted an apoptosis in approximately 75%); however, no significant change in the cell viability of Caco-2 cells or splenocytes was observed at any of the esculetin concentrations studied (data not shown).
DISCUSSION
The results obtained in this study confirm the beneficial effects of esculetin in the TNBS model of rat colitis, and these results are similar to those previously reported (15) . Moreover, the results reported here provide further information regarding the mechanism of action involved in the intestinal anti-inflammatory effect of esculetin. Additionally, the effects of esculetin are compared to the effects of prednisolone and sulphasalazine in both the acute and chronic stages of experimental colitis in rats.
In the acute experimental conditions, esculetin reduced the incidence of diarrhoea. This was similar to the effect obtained with prednisolone with regard to diarrhoea, indicating a restoration of the absorptive ability of the colon, which is profoundly altered as a consequence of the inflammatory process. Furthermore, esculetin treatment reduced the macroscopic score in both the acute and chronic experimental settings, similar to prednisolone and sulphasalazine treatment. Because it has been suggested that the most promising therapeutic strategies for IBD treatment are those that can restore epithelial integrity and functions, thereby attenuating mucosal inflammation, esculetin appears to be a potential candidate because it can significantly improve both the altered intestinal functions and mucosal inflammation in experimental colitis.
TNBS-induced colonic inflammation was associated with increased oxidative stress. This was evidenced by the depletion of glutathione and the increase oflipoperoxidation as determined by colonic MDA content. Glutathione is a tripeptide with a reactive sulphydryl group that can act at multiple levels of antioxidant defence. For its antioxidant function, reduced glutathione is converted to its oxidised state and is reduced back by glutathione reductase (2) . It has been previously described that glutathione levels are significantly depleted in the active stages of colitis, both in ulcerative colitis and in Crohn's disease, compared to the healthy colon or inactive colitis (25) . The potential importance of glutathione in inflammatory bowel disease has been suggested by prior animal studies demonstrating that glutathione depletion alters T-cell and macrophage function (25) and the pre-treatment with GSH increases the tissue thiol content, reduces lipid peroxidation and ameliorates the inflammatory process (26) . The antioxidant activity of esculetin may play an important role in its intestinal antiinflammatory effect, similar to prednisolone and sulphasalazine, because all treatments counteracted the GSH depletion observed in both the acute experimental model and the colitis relapse model. Furthermore, malondialdehyde is a major endproduct of polyunsaturated fatty acid oxidation and is frequently measured as an indicator of in vivo lipid peroxidation and oxidative stress. The reduction in the colonic content of MDA by either esculetin or prednisolone during the first week of the chronic model confirmed the antioxidant properties of esculetin.
The anti-inflammatory effects of esculetin, prednisolone and sulphasalazine were associated with an inhibition of colonic MPO activity. This enzyme is stored in azurophilic granules in polymorphonuclear neutrophils and macrophages, and is released into the extracellular fluid during the inflammatory process. MPO has powerful prooxidative and pro-inflammatory properties; therefore, a reduction in myeloperoxidase activity is regarded as a manifestation of the anti-inflammatory activity of a given compound (18) . The intense colonic insult induced by TNBS makes this parameter difficult to improve; however, esculetin inhibited MPO activity, with an efficacy similar to that observed with for the reference drugs currently used in IBD therapy.
In addition to the increase in colonic oxidative stress and neutrophil infiltration, the inflammation induced by TNBS resulted in upregulatedAP activity, which was attributable mainly to leukocytes (27) . AP can be also considered a sensitive biochemical marker of intestinal inflammation, which increases as a consequence of inducing a tissue-nonspecific isoform ofthis enzyme (27) . All treatments, including esculetin, inhibited AP activity during all weeks of the chronic experimental model. This confirmed the anti-inflammatory effect of this compound.
Because intestinal inflammation is usually related to tissue destruction, matrix metalloproteinase (MMP) activity was also evaluated in this study. MMPs are a group ofzinc-dependent endopeptidases that participate in extracellular matrix degradation and remodelling. They are primarily secreted as latent, inactive zymogens by various cell types, including mesenchymal cells, T-cells, monocytes, macrophages, neutrophils, keratinocytes and tumour cells (28) . Studies demonstrate that MMP-9 actively participates in the inflammatory process of lED, particularly during the acute phase. By contrast, MMP-2 is an important modulator of inflammatory reactions and the healing process in lED (28) . Our study showed that esculetin, prednisolone and sulphasalazine were able to inhibit the MMP-9 activity during the first week in the chronic experimental setting and simultaneously maintained the protective activity of colonic MMP-2. It is possible that the effect of esculetin or prednisolone on MMP-9 activity is related, at least in part, to the ability of these compounds to reduce colonic IL-1ã nd TNF-a levels and these are pro-inflammatory cytokines that are involved in the expression of different inflammatory proteins, including MMPs.
In this regard, several studies support an important role for TNF-a in human lED. It has been observed that the administration of anti-TNF-a monoclonal antibodies resulted in beneficial responses in patients with Crohn's disease and in animal models of lED (29) . TNF-a plays a crucial role in the initiation and maintenance of inflammation and immunity. It is a multifunctional cytokine produced primarily by activated monocytes/macrophages. Esculetin and prednisolone reduced the TNF-a levels in the inflamed colon in the acute colitis model and during the first week of the chronic experimental model. These results indicated that this coumarin derivative also has an immunomodulatory effect. Another result that supports this hypothesis is related to the reduction in IL-1~levels, which is also an important pro-inflammatory cytokine. The reduction in IL-1l evels occurred in animals treated with esculetin and prednisolone during the first week of the chronic experimental model. IL-1~is a cytokine produced by various cell types and has been shown to have a major role in inflammatory and immunological responses. In experimental colitis, it has been reported to be a key mediator and a reliable marker of inflammation (30) . It was reported that there is enhanced production ofIL-1~in colonic mononuclear cells isolated from lED patients (30) . Therefore, the inhibition of secretion of this cytokine in cell culture confirmed the anti-inflammatory activity ofesculetin. Additionally, at the highest concentration tested, this compound inhibited the secretion of IL-2 and IFN-y by splenocytes, confirming its immunomodulatory properties. Notably, some antioxidant molecules can restrain pro-inflammatory cytokines, and these finding are promising for lED treatment.
Histologically, the acute process is characterised by enhanced inflammatory cell infiltration. This is accompanied by extensive mucosal and/or transmural injury, including an increase in vascular permeability, disruption of the extracellular matrix, oedema, epithelial cell damage, and erosions and ulcers. The animals treated with esculetin, prednisolone or sulphasalazine showed an amelioration in the histological parameters, as evidenced by a significant reduction in the microscopic score. A homeostatic balance between proliferation and apoptosis is essential for normal gut morphology and function. It has been observed in patients with CD and DC that an increase in epithelial cell apoptosis leads to the functional loss of normal absorptive capacity with the inappropriate secretion of intestinal fluid and electrolytes. This is typical of immature crypt epithelial cells, and the clinical signs include diarrhoea, abdominal cramps, excessive gas, and bloating (31) . The loss of colonic epithelium in active DC occurs primarily because of crypt epithelial cell apoptosis. Consequently, the inhibition ofpathological apoptosis could be a symptomatic treatment option for patients with severe diarrhoea (49) and may also reduce villus atrophy and epithelial destruction (31) . Our results showed that esculetin reduced the number of intestinal epithelial cells in the crypt in the acute model and during all weeks of the chronic relapse colitis model. This effect may be related to the antioxidant properties of esculetin. There is ample evidence to connect apoptosis with oxidative stress during diverse processes (32) . Exposure to low doses ofreactive oxygen molecules or a depletion of cellular antioxidants has been shown to result in apoptosis, and conversely, apoptosis can be blocked by the addition of antioxidant compounds (32) . Additionally, a recent study showed that esculetin significantly decreased the levels of the proapoptotic proteins, t-Bid, Bak and Bad and significantly increased the levels of the anti-apoptotic proteins, Bcl-2 and Bcl-x, in the liver. This activity is related to the antioxidant property of esculetin (32) .
Our results showed that in this experimental model of rat colitis, esculetin produced similar intestinal anti-inflammatory effects compared to prednisolone and showed higher efficacy than sulphasalazine. Inflammatory bowel diseases are characterized by a complex inflammatory cascade that is responsible for the development and chronicity of the lesions; however, the exact order of events has not yet been established. For this reason, it is not possible to clearly describe the specific mechanisms involved in the beneficial effects of esculetin. However, we can conclude that the activity of this compound is due to either its antioxidant or immunomodulatory properties, and these properties can be closely related to each other.
